NATIONAL UNIV CORPORATION HAMAMATSU UNIV SCHOOL OF MEDICINE has a total of 26 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and computer technology are PUBLIC UNIVERSITY CORP NARA MEDICAL UNIVERSITY, FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA IZHEVSKAYA and GEN HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | United States | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | China | 1 | |
#5 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Unno Naoki | 8 |
#2 | Tanaka Hiroki | 6 |
#3 | Inoue Keisuke | 6 |
#4 | Yata Tatsuro | 6 |
#5 | Makinose Yuichi | 4 |
#6 | Kaneta Noboru | 4 |
#7 | Shimmura Chie | 3 |
#8 | Tsuchiya Kenji | 3 |
#9 | Kikuchi Hirotoshi | 3 |
#10 | Suzuki Katsuaki | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021010359A1 | Fragrance composition | |
WO2020184703A1 | Pharmaceutical composition for treating aortic aneurysm | |
WO2019054432A1 | Pharmaceutical composition for treatment of aortic aneurysm | |
WO2018143357A1 | Method for screening substance having high affinity for target substance | |
US2017224210A1 | Inattention measurement device, system, and method | |
EP2985345A1 | Method for inhibiting proliferation of high lix1l-expressing tumor cell, and tumor cell proliferation-inhibiting peptide | |
EP2899265A1 | Sperm activating method |